2,2'-dipyridylamine has been researched along with platinum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyukgungor, O; Harrison, WT; Icsel, C; Kaya, Y; Samli, H; Yilmaz, VT | 1 |
| Abedi, A; Amani, V; Bozorgmehr, M; Lighvan, ZM; Mirzadegan, E; Mohammadi, F; Safari, N; Shahsavar, F; Zarnani, AH | 1 |
2 other study(ies) available for 2,2'-dipyridylamine and platinum
| Article | Year |
|---|---|
New palladium(II) and platinum(II) 5,5-diethylbarbiturate complexes with 2-phenylpyridine, 2,2'-bipyridine and 2,2'-dipyridylamine: synthesis, structures, DNA binding, molecular docking, cellular uptake, antioxidant activity and cytotoxicity.
Topics: 2,2'-Dipyridyl; Antioxidants; Barbiturates; Benzothiazoles; Biological Transport; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Coordination Complexes; DNA; Humans; Ligands; Molecular Docking Simulation; Palladium; Picrates; Plasmids; Platinum; Pyridines; Sulfonic Acids | 2015 |
A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Topics: 2,2'-Dipyridyl; Amniotic Fluid; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Dimethylformamide; DNA; Drug Resistance, Neoplasm; Epithelial Cells; Female; Humans; Intercalating Agents; Male; MCF-7 Cells; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Prostatic Neoplasms; Spectrophotometry | 2016 |